- Home
- EBS vs XFLT Comparison
EBS vs XFLT Comparison
Compare EBS & XFLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EBS
- XFLT
- Stock Information
- Founded
- EBS 1998
- XFLT 2017
- Country
- EBS United States
- XFLT United States
- Employees
- EBS N/A
- XFLT N/A
- Industry
- EBS Biotechnology: Pharmaceutical Preparations
- XFLT Investment Managers
- Sector
- EBS Health Care
- XFLT Finance
- Exchange
- EBS Nasdaq
- XFLT Nasdaq
- Market Cap
- EBS 459.6M
- XFLT 380.6M
- IPO Year
- EBS 2006
- XFLT N/A
- Fundamental
- Price
- EBS $9.40
- XFLT $6.89
- Analyst Decision
- EBS Strong Buy
- XFLT
- Analyst Count
- EBS 2
- XFLT 0
- Target Price
- EBS $14.00
- XFLT N/A
- AVG Volume (30 Days)
- EBS 1.6M
- XFLT 336.2K
- Earning Date
- EBS 11-06-2024
- XFLT 01-01-0001
- Dividend Yield
- EBS N/A
- XFLT 14.17%
- EPS Growth
- EBS N/A
- XFLT N/A
- EPS
- EBS N/A
- XFLT N/A
- Revenue
- EBS $1,125,500,000.00
- XFLT N/A
- Revenue This Year
- EBS $7.98
- XFLT N/A
- Revenue Next Year
- EBS $6.62
- XFLT N/A
- P/E Ratio
- EBS N/A
- XFLT N/A
- Revenue Growth
- EBS 2.05
- XFLT N/A
- 52 Week Low
- EBS $1.42
- XFLT $6.01
- 52 Week High
- EBS $15.10
- XFLT $7.76
- Technical
- Relative Strength Index (RSI)
- EBS 50.73
- XFLT 46.79
- Support Level
- EBS $8.12
- XFLT $6.90
- Resistance Level
- EBS $12.68
- XFLT $7.02
- Average True Range (ATR)
- EBS 0.91
- XFLT 0.04
- MACD
- EBS -0.18
- XFLT -0.01
- Stochastic Oscillator
- EBS 33.67
- XFLT 18.75
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.
About XFLT XAI Octagon Floating Rate & Alternative Income Term Trust of Beneficial Interest
XAI Octagon Floating Rate & Alternative Income Trust is a diversified, closed-end management investment company which primarily invests in a dynamically managed portfolio of floating-rate credit instruments and other structured credit investments within the private markets. The Trust's investment objective is to seek attractive total return with an emphasis on income generation across multiple stages of the credit cycle.